EQL Pharma AB (publ) has recruited Axel Schörling as a new Chief Operating Officer. Axel will begin his employment in mid-January 2018. Mr. Schörling will be responsible for sourcing, supply chain, pricing and working capital strategies. He has a background as a management consultant at BearingPoint and most recently as a Director in the Business Controlling team at Perstorp. Mr. Schörling will play a key role in EQL's continued development and growth.